Literature DB >> 26085685

Cell-Intrinsic gp130 Signaling on CD4+ T Cells Shapes Long-Lasting Antiviral Immunity.

James A Harker1, Kurt A Wong2, Aleksandr Dolgoter2, Elina I Zuniga1.   

Abstract

The IL-6 cytokine family utilizes the common signal transduction molecule gp130, which can mediate a diverse range of outcomes. To clarify the role of gp130 signaling in vivo during acute viral infection, we infected Cd4-cre Il6st(fl/fl) mice, in which gp130 is conditionally ablated in T cells, with acute lymphocytic choriomeningitis virus. We found that by day 12, but not at day 8, after infection the number of virus-specific CD4(+) T cells was reduced in the absence of gp130, and this was sustained for up to 2 mo postinfection. Additionally, gp130-deficient T follicular helper cells had lower expression of Maf, IL-21, and ICOS, and this was accompanied by a reduction in the proportion of germinal center B cells and plasmablasts. Remarkably, at 2 mo postinfection the proportion of IgG2a/c(+) memory B cells and the systemic levels of lymphocytic choriomeningitis virus-specific IgG2 Abs were dramatically decreased, whereas there was a corresponding increase in IgG1(+) memory B cells and virus-specific IgG1 Abs. In the same animals gp130-deficient virus-specific CD8(+) T cells showed a reduced proportion of memory cells, which expressed lower levels of Tcf7, and displayed diminished recall responses on secondary infection. Mixed bone marrow chimeras revealed that the aforementioned gp130 effects on CD4(+) T cells were cell intrinsic. Overall, our data show that gp130 signaling in T cells influences the quantity and quality of long-lasting CD4(+) T cell responses as well as CD8(+) T cell- and Ab-mediated immunity after acute viral infection.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26085685      PMCID: PMC4506854          DOI: 10.4049/jimmunol.1402402

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

1.  Differentiation and persistence of memory CD8(+) T cells depend on T cell factor 1.

Authors:  Xinyuan Zhou; Shuyang Yu; Dong-Mei Zhao; John T Harty; Vladimir P Badovinac; Hai-Hui Xue
Journal:  Immunity       Date:  2010-08-27       Impact factor: 31.745

2.  Cell-intrinsic IL-27 and gp130 cytokine receptor signaling regulates virus-specific CD4⁺ T cell responses and viral control during chronic infection.

Authors:  James A Harker; Aleksandr Dolgoter; Elina I Zuniga
Journal:  Immunity       Date:  2013-08-29       Impact factor: 31.745

Review 3.  gp130 at the nexus of inflammation, autoimmunity, and cancer.

Authors:  J S Silver; C A Hunter
Journal:  J Leukoc Biol       Date:  2010-07-07       Impact factor: 4.962

4.  IL-21 deficiency influences CD8 T cell quality and recall responses following an acute viral infection.

Authors:  John S Yi; Jennifer T Ingram; Allan J Zajac
Journal:  J Immunol       Date:  2010-09-15       Impact factor: 5.422

5.  In vivo regulation of Bcl6 and T follicular helper cell development.

Authors:  Amanda C Poholek; Kyle Hansen; Sairy G Hernandez; Danelle Eto; Anmol Chandele; Jason S Weinstein; Xuemei Dong; Jared M Odegard; Susan M Kaech; Alexander L Dent; Shane Crotty; Joe Craft
Journal:  J Immunol       Date:  2010-06-02       Impact factor: 5.422

6.  HIV-specific IL-21 producing CD4+ T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control.

Authors:  Feng Yun Yue; Calvin Lo; Ali Sakhdari; Erika Yue Lee; Colin M Kovacs; Erika Benko; Jun Liu; Haihan Song; R Brad Jones; Prameet Sheth; Duncan Chege; Rupert Kaul; Mario A Ostrowski
Journal:  J Immunol       Date:  2010-06-02       Impact factor: 5.422

7.  T-cell-specific deletion of gp130 renders the highly susceptible IL-10-deficient mouse resistant to intestinal nematode infection.

Authors:  Nicolas Fasnacht; Marina C Greweling; Mariela Bollati-Fogolín; Angela Schippers; Werner Müller
Journal:  Eur J Immunol       Date:  2009-08       Impact factor: 5.532

8.  Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and cross-sectional study.

Authors:  Alexandre Iannello; Mohamed-Rachid Boulassel; Suzanne Samarani; Olfa Debbeche; Cécile Tremblay; Emil Toma; Jean-Pierre Routy; Ali Ahmad
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

9.  IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H).

Authors:  Joanne L Jones; Chia-Ling Phuah; Amanda L Cox; Sara A Thompson; Maria Ban; Jacqueline Shawcross; Amie Walton; Stephen J Sawcer; Alastair Compston; Alasdair J Coles
Journal:  J Clin Invest       Date:  2009-06-22       Impact factor: 14.808

10.  T cell-derived interleukin (IL)-21 promotes brain injury following stroke in mice.

Authors:  Benjamin D S Clarkson; Changying Ling; Yejie Shi; Melissa G Harris; Aditya Rayasam; Dandan Sun; M Shahriar Salamat; Vijay Kuchroo; John D Lambris; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Exp Med       Date:  2014-03-10       Impact factor: 14.307

View more
  11 in total

1.  Cutting Edge: T Cell-Dependent Plasmablasts Form in the Absence of Single Differentiated CD4+ T Cell Subsets.

Authors:  Jessica A Kotov; Marc K Jenkins
Journal:  J Immunol       Date:  2018-12-14       Impact factor: 5.422

2.  T Cell-Intrinsic IL-6R Signaling Is Required for Optimal ICOS Expression and Viral Control during Chronic Infection.

Authors:  Kurt A Wong; James A Harker; Aleksandr Dolgoter; Nuha Marooki; Elina I Zuniga
Journal:  J Immunol       Date:  2019-08-14       Impact factor: 5.422

3.  Co-expression of a PD-L1-specific chimeric switch receptor augments the efficacy and persistence of CAR T cells via the CD70-CD27 axis.

Authors:  Le Qin; Yuanbin Cui; Tingjie Yuan; Dongmei Chen; Ruocong Zhao; Shanglin Li; Zhiwu Jiang; Qiting Wu; Youguo Long; Suna Wang; Zhaoyang Tang; Huixia Pan; Xiaoping Li; Wei Wei; Jie Yang; Xuequn Luo; Zhenfeng Zhang; Qiannan Tang; Pentao Liu; Robert Weinkove; Yao Yao; Dajiang Qin; Jean Paul Thiery; Peng Li
Journal:  Nat Commun       Date:  2022-10-13       Impact factor: 17.694

4.  Markers of systemic inflammation are positively associated with influenza vaccine antibody responses with a possible role for ILT2(+)CD57(+) NK-cells.

Authors:  Emilie Picard; Sarah Armstrong; Melissa K Andrew; Laura Haynes; Mark Loeb; Graham Pawelec; George A Kuchel; Janet E McElhaney; Chris P Verschoor
Journal:  Immun Ageing       Date:  2022-05-26       Impact factor: 9.701

5.  Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.

Authors:  James A Harker; Kurt A Wong; Simone Dallari; Phuc Bao; Aleksandr Dolgoter; Yeara Jo; Ellen J Wehrens; Monica Macal; Elina I Zuniga
Journal:  J Virol       Date:  2018-05-29       Impact factor: 5.103

6.  Early IL-6 signalling promotes IL-27 dependent maturation of regulatory T cells in the lungs and resolution of viral immunopathology.

Authors:  Chloe J Pyle; Faith I Uwadiae; David P Swieboda; James A Harker
Journal:  PLoS Pathog       Date:  2017-09-27       Impact factor: 6.823

7.  mRNA and miRNA profiling of Zika virus-infected human umbilical cord mesenchymal stem cells identifies miR-142-5p as an antiviral factor.

Authors:  Rak-Kyun Seong; Jae Kyung Lee; Geum Joon Cho; Mukesh Kumar; Ok Sarah Shin
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

8.  B cell-derived IL-27 promotes control of persistent LCMV infection.

Authors:  Isaraphorn Pratumchai; Jaroslav Zak; Zhe Huang; Booki Min; Michael B A Oldstone; John R Teijaro
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-18       Impact factor: 12.779

9.  CD3+CD4+gp130+ T Cells Are Associated With Worse Disease Activity in Systemic Lupus Erythematosus Patients.

Authors:  Nur Diyana Mohd Shukri; Aziz Farah Izati; Wan Syamimee Wan Ghazali; Che Maraina Che Hussin; Kah Keng Wong
Journal:  Front Immunol       Date:  2021-06-04       Impact factor: 7.561

10.  Regulation of the germinal center and humoral immunity by interleukin-21.

Authors:  Stuart G Tangye; Cindy S Ma
Journal:  J Exp Med       Date:  2020-01-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.